Abstract:Background: Severely injured trauma patients suffering from traumatic cardiac arrest (TCA) and requiring cardiopulmonary resuscitation (CPR) rarely survive. The role of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) performed early after hospital admission in patients with TCA is not well-defined. As the use of REBOA increases, there is great interest in knowing if there is a survival benefit related to the early use of REBOA after TCA. Using data from the ABOTrauma Registry, we aimed to stu… Show more
“…While a survival advantage for REBOA was seen in hypotensive patients who did not arrest, in those who did, regardless of when CPR was initiated, there was no benefit seen. Data from the ABOTrauma registry were used to examine the outcomes associated with REBOA in those who were in traumatic cardiac arrest 30 . In this case series of patients undergoing prehospital CPR, the observed mortality of 19 of the 26 arresting patients was seen to be better than the expected mortality according to Revised Injury Severity Calculation II, with the conclusion being that the use of REBOA in this clinical circumstance warrants further investigation.…”
A Western Trauma Association Critical Decisions Algorithm: REBOA, providing a practical approach to the use of REBOA in trauma, based on the existing scientific evidence, expert opinion and the input of the Western Trauma Association membership. @WesternTrauma #REBOA
“…While a survival advantage for REBOA was seen in hypotensive patients who did not arrest, in those who did, regardless of when CPR was initiated, there was no benefit seen. Data from the ABOTrauma registry were used to examine the outcomes associated with REBOA in those who were in traumatic cardiac arrest 30 . In this case series of patients undergoing prehospital CPR, the observed mortality of 19 of the 26 arresting patients was seen to be better than the expected mortality according to Revised Injury Severity Calculation II, with the conclusion being that the use of REBOA in this clinical circumstance warrants further investigation.…”
A Western Trauma Association Critical Decisions Algorithm: REBOA, providing a practical approach to the use of REBOA in trauma, based on the existing scientific evidence, expert opinion and the input of the Western Trauma Association membership. @WesternTrauma #REBOA
“…23,24 Blind placement technique using anatomic landmarks and estimated distance has been developed for the use of REBOA in trauma patients. 25,26 This blind technique is likely adequate for use during NTCA and is currently in use in a Phase 1 clinical trial at Yale University. 27 Once in the desired position the balloon at the tip of the REBOA catheter is inflated with a radiopaque solution, fully occluding the aorta.…”
Resuscitative endovascular balloon occlusion of the aorta (REBOA) has been proposed as a novel approach to managing non‐traumatic cardiac arrest (NTCA). During cardiac arrest, cardiac output ceases and perfusion of vital organs is compromised. Traditional advanced cardiac life support (ACLS) measures and cardiopulmonary resuscitation are often unable to achieve return of spontaneous circulation (ROSC). During insertion of REBOA a balloon‐tipped catheter is placed into the femoral artery and advanced in a retrograde manner into the aorta while the patient is undergoing cardiopulmonary resuscitation (CPR). The balloon is then inflated to fully occlude the aorta. The literature surrounding the use of aortic occlusion in non‐traumatic cardiac arrest is limited to animal studies, case reports and one recent non‐controlled feasibility trial. In both human and animal studies, preliminary data show that REBOA may improve coronary and cerebral perfusion pressures and key physiologic parameters during cardiac arrest resuscitation, and animal data have demonstrated improved rates of ROSC. Multiple questions remain before REBOA can be considered as an adjunct to ACLS. If demonstrated to be effective clinically, REBOA represents a potentially cost‐effective and generalizable intervention that may improve quality of life for patients with non‐traumatic cardiac arrest.
“…Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a minimally invasive procedure being increasingly utilized to prevent patients with non-compressible torso hemorrhage (NCTH) from exsanguination. It is used as a bridge to surgical bleeding control to gain time during the management of hemorrhagic shock as part of the EndoVascular resuscitation and Trauma Management (EVTM) concept (1)(2)(3)(4)(5)(6)(7). Access to the common femoral artery (CFA) is essential for performing REBOA and is regularly gained by different medical specialists including vascular surgeons, interventional radiologists, anesthetists, and emergency physicians (8).…”
Section: Introductionmentioning
confidence: 99%
“…With the present study we aimed to describe by who, how (regarding the access) and where REBOA is successfully being performed, using data from the unique international ABO (Aortic Balloon Occlusion) Trauma registry. We believe that this is highly relevant since the indications for the use of REBOA are also starting to include non-traumatic causes of hemodynamic instability or even cardiopulmonary resuscitation (CPR) (2,17).…”
BackgroundResuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is a minimally invasive procedure being increasingly utilized to prevent patients with non-compressible torso hemorrhage from exsanguination. The increased use of REBOA is giving rise to discussion about “Who is and who should be performing it?”.MethodsData from the international ABO (Aortic Balloon Occlusion) Trauma registry from between November 2014 and April 2020 were analyzed concerning the question: By who, how and where is REBOA being performed? The registry collects retrospective and prospective data concerning use of REBOA in trauma patients.ResultsDuring the study period, 259 patients had been recorded in the registry, 72.5% (n=188) were males with a median (range) age of 46 (10-96) years. REBOA was performed in the ER in 50.5%, in the OR in 41.5% and in the angiography suite in 8% of patients. In 54% of the patients REBOA was performed by surgeons (trauma surgeons 28%, vascular surgeons 22%, general surgeons 4%) and in 46% of the patients by non-surgeons (emergency physicians 31%, radiologists 9.5%, anesthetists 5.5%). Common Femoral Artery (CFA) access was achieved by use of external anatomic landmarks and palpation alone in 119 patients (51%), by cut down in 57 patients (24%), using ultrasound in 49 patients (21%) and by fluoroscopy in 9 patients (4%). Significant differences between surgeons and non-surgeons were found regarding patient’s age, injury severity, access methods, place where REBOA was performed, location patients were taken to from the emergency room and mortality.ConclusionA substantial number of both surgical and non-surgical medical disciplines are successfully performing REBOA to an almost equal extent. Surgical cut down is used less frequently as access to the CFA compared with reports in older literature and puncture by use of external anatomic landmarks and palpation alone is used with a high rate of success. Instead of discussing “Who should be performing REBOA?” future research should focus on “Which patient benefits most from REBOA?”.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.